John co-founder of Pangea Bio and Kadence Bio, focused on drug development using natural molecules. He previously led Quercis Pharma and held leadership roles at COMPASS Pathways, helping raise over $260 million. John began his career at Boston Consulting Group and holds degrees from MIT, Cambridge, and Harvard. He has lived in the UK, US, Belgium, and Lebanon.